5 Essentials for Building a Market Access Strategy That Delivers

Market Access isn’t just about launch — it’s about long-term value.

For biotech and pharma companies, particularly those with limited resources or first-in-class assets, your Market Access strategy can make or break commercial success.

Here are five critical considerations to keep in mind:

1. Don’t wait until Phase III

Market Access isn’t a task for the finish line — it should inform early decisions. Aligning payer needs with development strategy from day one helps avoid delays, redesigns, or missed opportunities down the line.

• Start with the end in mind

2. Know your value — and prove it

Efficacy isn’t enough. You must clearly define how your product delivers value — to patients, health systems, and payers — and back it with credible, relevant evidence.

• Value is only real if it’s recognised

3. Think globally, act locally

HTA processes, pricing rules, and reimbursement timelines vary significantly across countries. A global plan that adapts to local realities is essential for sustainable access.

• Different markets, different mindsets

4. Build access into your trial design

Clinical trials should serve more than regulatory approval — they must also support the value proposition. Aligning endpoints, comparators and populations with payer expectations is crucial.

• Your data defines your destiny

5. Plan for evolving expectations

Payer expectations are shifting fast. Whether it’s real-world evidence, cost-effectiveness, or outcome-based models — your strategy needs to evolve with the landscape.

• Access isn’t static — and your strategy shouldn’t be either

At tranScrip, we partner with biotech and pharma companies globally to accelerate the development and maximise the value of their products. We provide strategic, therapeutic and operational expertise across the entire product lifecycle – from TRANslation to preSCRIPtion.

We design and deliver integrated Market Access strategies that align clinical development, regulatory planning, and payer expectations from the outset.

Whether you’re preparing for early-phase development, navigating pricing and reimbursement, or expanding into new markets, we help accelerate your product’s path to patient.

Ready to build smarter access from the start? Let’s connect > Contact us